FDA Warned Millipore on H1N1 Test Marketing | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated to include comments from a Millipore spokesperson.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration disclosed on its website Tuesday that it had sent a warning letter to Millipore in September regarding the firm's promotional materials for influenza diagnostics products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.